14 articles on diagnostics in longevity medicine.
View all news →
Mayo Clinic Executive Health Program
Executive Health vs Longevity Clinic: Which Preventive Health Path Should You Choose in 2026?
A decision framework for choosing executive health, concierge prevention, or a longevity clinic in 2026 based on risk profile, diagnostics, follow-up, budget, and red flags.
A Framework for an Effective Healthy Longevity ClinicPeer-reviewed
What Should a Longevity Health Assessment Include in 2026?
A practical buyer’s guide to longevity health assessments: biomarkers, imaging, genetics, fitness testing, costs, and the questions to ask before booking.
The Business of 'Not Aging': The Gap Between What's Sold and What Science Supports
BBC examines the longevity industry boom: extreme diagnostics, expensive programs, and the key question — what part is real prevention and what part is marketing?
Biograph and the 'Diagnostic Day': Why Luxury Is No Longer the Product
An inside look at Biograph: 6 hours, 30+ tests, and 1,000+ data points. The clinical question isn't 'what do you measure' — it's what decisions you change with the data.
2025 in Review: The Year Longevity Medicine Stopped Being Theoretical
A comprehensive review of 2025's longevity milestones: AI-driven drug deals, clinic proliferation, biomarker standardization, and the XPRIZE Healthspan competition reaching its final phase.
Longevity Clinics Get Their First Global Directory — And It Reveals How Fast the Industry Is Growing
Longevity.Technology launches Longevity Clinics World, a directory of 350+ pre-validated clinics globally. The move signals an industry maturing from niche to mainstream.
NAD+ in Humans: The Review That Cuts Through the Hype (Nature Metabolism, 2025)
A systematic review in Nature Metabolism concludes that clinical evidence for NAD+ supplementation in humans remains scarce and results are heterogeneous. More research needed.